SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma

British Journal of Cancer

Volumn 111, Issue 11, 2014, Pages 2122-2130

  Lee, S H ^a   Oh, S Y ^b   Do, S I ^a   Lee, H J ^a   Kang, H J ^c   Rho, Y S ^d   Bae, W J ^e   Lim, Y C ^c  

^a School of Medicine   (South Korea)

^b Korea University   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

^d Ewha Womans University School of Medicine   (South Korea)

^e Hallym University College of Medicine   (South Korea)

Author keywords

cancer stem cell; head and neck squamous cell carcinomas; SOX2; target therapy

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CYCLIN B1; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SOX2; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; CCNB1 PROTEIN, HUMAN; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX; TUMOR PROTEIN;

ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENICITY; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR INVASION; ANIMAL; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; DRUG RESISTANCE; EPITHELIAL MESENCHYMAL TRANSITION; HEAD AND NECK NEOPLASMS; MORTALITY; MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN B1; DRUG RESISTANCE, NEOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; HEAD AND NECK NEOPLASMS; HUMANS; MICE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; SOXB1 TRANSCRIPTION FACTORS;

EID: 84927175394     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.528     Document Type: Article

References (37)

1. Albers AE, Chen C, Koberle B, Qian X, Klussmann JP, Wollenberg B, Kaufmann AM (2012) Stem cells in squamous head and neck cancer. Crit Rev Oncol Hematol 81: 224-240.
2. Archer SY, Johnson J, Kim HJ, Ma Q, Mou H, Daesety V, Meng S, Hodin RA (2005) The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells. Am J Physiol Gastrointest Liver Physiol 289: G696-G703.
3. Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, Kim SY, Wardwell L, Tamayo P, Gat-Viks I, Ramos AH, Woo MS, Weir BA, Getz G, Beroukhim R, O'Kelly M, Dutt A, Rozenblatt-Rosen O, Dziunycz P, Komisarof J, Chirieac LR, Lafargue CJ, Scheble V, Wilbertz T, Ma C, Rao S, Nakagawa H, Stairs DB, Lin L, Giordano TJ, Wagner P, Minna JD, Gazdar AF, Zhu CQ, Brose MS, Cecconello I, Jr UR, Marie SK, Dahl O, Shivdasani RA, Tsao MS, Rubin MA, Wong KK, Regev A, Hahn WC, Beer DG, Rustgi AK, Meyerson M (2009) SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 41: 1238-1242.
4. Begg AC (2012) Predicting recurrence after radiotherapy in head and neck cancer. Semin Radiat Oncol 22: 108-118.
5. Bertrand FE, Augus CW, Partis WJ, Sigounas G (2012) Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch. Cell Cycle 11: 4344-4351.
6. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP (2005) Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 114: 806-816.
7. Chen C, Zimmermann M, Tinhofer I, Kaufmann AM, Albers AE (2013) Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma. Cancer Lett 338: 47-56.
8. Chen KG, Sikic BI (2012) Molecular pathways: regulation and therapeutic implications of multidrug resistance. Clin Cancer Res 18: 1863-1869.
9. Chen S, Xu Y, Chen Y, Li X, Mou W, Wang L, Liu Y, Reisfeld RA, Xiang R, Lv D, Li N (2012) SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells. PLoS One 7: e36326.
10. Clevers H (2006) Wnt/beta-catenin signalling in development and disease. Cell 127: 469-480.
11. Du L, Yang Y, Xiao X, Wang C, Zhang X, Wang L, Zhang X, Li W, Zheng G, Wang S, Dong Z (2011) SOX2 nuclear expression is closely associated with poor prognosis in patients with histologically node-negative oral tongue squamous cell carcinoma. Oral Oncol 47: 709-713.
12. Han X, Fang X, Lou X, Hua D, Ding W, Foltz G, Hood L, Yuan Y, Lin B (2012) Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients. PLoS One 7: e41335.
13. Herreros-Villanueva M, Zhang JS, Koenig A, Abel EV, Smyrk TC, Bamlet WR, de Narvajas AA, Gomez TS, Simeone DM, Bujanda L, Billadeau DD (2013) SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells. Oncogenesis 2: e61.
14. Howell GM, Grandis JR (2005) Molecular mediators of metastasis in head and neck squamous cell carcinoma. Head Neck 27: 710-717.
15. Ikushima H, Todo T, Ino Y, Takahashi M, Miyazawa K, Miyazono K (2009) Autocrine TGF-beta signalling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 5: 504-514.
16. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ (2003) Cancer statistics, 2003. CA Cancer J Clin 53: 5-26.
17. Keramari M, Razavi J, Ingman KA, Patsch C, Edenhofer F, Ward CM, Kimber SJ (2010) SOX2 is essential for formation of trophectoderm in the preimplantation embryo. PLoS One 5: e13952.
18. Kumar SM, Liu S, Lu H, Zhang H, Zhang PJ, Gimotty PA, Guerra M, Guo W, Xu X (2012) Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene 31: 4898-4911.
19. Lai SY, Childs EE, Xi S, Coppelli FM, Gooding WE, Wells A, Ferris RL, Grandis JR (2005) Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Oncogene 24: 4442-4449.
20. Leis O, Eguiara A, Lopez-Arribillaga E, Alberdi MJ, Hernandez-Garcia S, Elorriaga K, Pandiella A, Rezola R, Martin AG (2012) SOX2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 31: 1354-1365.
21. Li Y, Hively WP, Varmus HE (2000) Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene 19: 1002-1009.
22. Lim YC, Oh SY, Cha YY, Kim SH, Jin X, Kim H (2011) Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas. Oral Oncol 47: 83-91.
23. Liu J, Ruan B, You N, Huang Q, Liu W, Dang Z, Xu W, Zhou T, Ji R, Cao Y, Li X, Wang D, Tao K, Dou K (2013) Downregulation of miR-200a induces EMT phenotypes and CSC-like signatures through targeting the b-catenin pathway in hepatic oval cells. PLoS One 8: e79409.
24. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
25. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Scholer H, Smith A Nichols J (1998) Formation of pluripotent stem cells in the mammalian embryo depends. Cell 95: 379-391.
26. Okubo T, Clark C, Hogan BL (2009) Cell lineage mapping of taste bud cells and keratinocytes in the mouse tongue and soft palate. Stem Cells 27: 442-450.
27. Piva M, Domenici G, Iriondo O, Rabano M, Simoes BM, Comaills V, Barredo I, Lopez-Ruiz JA, Zabalza I, Kypta R, Vivanco Md (2014) SOX2 promotes tamoxifen resistance in breast cancer cells. EMBO Mol Med 6: 66-79.
28. Rybak AP, Tang D (2013) SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells. Cell Signal 25: 2734-2742.
29. Sarkar A, Hochedlinger K (2013) The SOX family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cel 12: 15-30.
30. Schrock A, Bode M, Goke FJ, Bareiss PM, Schairer R, Wang H, Weichert W, Franzen A, Kirsten R, van Bremen T, Queisser A, Kristiansen G, Heasley L, Bootz F, Lengerke C, Perner S (2014) Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma. Carcinogenesis 35: 1636-1642.
31. Schrock A, Goke F, Wagner P, Bode M, Franzen A, Braun M, Huss S, Agaimy A, Ihrler S, Menon R, Kirsten R, Kristiansen G, Bootz F, Lengerke C, Perner S (2013) Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer. PLoS One 8: e59201.
32. Tang XB, Shen XH, Li L, Zhang YF, Chen GQ (2013) SOX2 overexpression correlates with poor prognosis in laryngeal squamous cell carcinoma. Auris Nasus Larynx 40: 481-486.
33. White RA, Neiman JM, Reddi A, Han G, Birlea S, Mitra D, Dionne L, Fernandez P, Murao K, Bian L, Keysar SB, Goldstein NB, Song N, Bornstein S, Han Z, Lu X, Wisell J, Li F, Song J, Lu SL, Jimeno A, Roop DR, Wang XJ (2013) Epithelial stem cell mutations that promote squamous cell carcinoma metastasis. J Clin Invest 123: 4390-4404.
34. Yamano Y, Uzawa K, Saito K, Nakashima D, Kasamatsu A, Koike H, Kouzu Y, Shinozuka K, Nakatani K, Negoro K, Fujita S, Tanzawa H (2010) Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma. Int J Cancer 126: 437-449.
35. Yu F, Sim AC, Li C, Li Y, Zhao X, Wang DY, Loh KS (2013) Identification of a subpopulation of nasopharyngeal carcinoma cells with cancer stemlike cell properties by high aldehyde dehydrogenase activity. Laryngoscope 123: 1903-1911.
36. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP (2008) Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68: 4311-4320.
37. Zhang Z, Filho MS, Nor JE (2012) The biology of head and neck cancer stem cells. Oral Oncol 48: 1-9.